ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 144 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,514 | +8414.0% | 92,283 | +1881.2% | 0.02% | – |
| Q2 2023 | $100 | -46.8% | 4,658 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $188 | -13.4% | 4,658 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $217 | -99.9% | 4,658 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $242,000 | +10.0% | 4,658 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $220,000 | -33.7% | 4,658 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $332,000 | -55.3% | 4,658 | -53.0% | 0.00% | -33.3% |
| Q4 2021 | $742,000 | +9.0% | 9,919 | -17.2% | 0.00% | 0.0% |
| Q3 2021 | $681,000 | +29.2% | 11,982 | 0.0% | 0.00% | +50.0% |
| Q2 2021 | $527,000 | -65.4% | 11,982 | -71.5% | 0.00% | -84.6% |
| Q3 2015 | $1,521,000 | -12.0% | 42,100 | +9.6% | 0.01% | -7.1% |
| Q2 2015 | $1,728,000 | +46.9% | 38,400 | 0.0% | 0.01% | +40.0% |
| Q1 2015 | $1,176,000 | – | 38,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |